Suppr超能文献

酵母转化知母皂苷 A-III 的立体选择性研究。

Stereoselective biotransformation of timosaponin A-III by Saccharomyces cerevisiae.

机构信息

Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.

出版信息

J Microbiol Biotechnol. 2011 Jun;21(6):582-9.

Abstract

Bioconversion of timosaponin A-III (TA-III), one of the major steroidal saponins isolated from the rhizomes of Anemarrhenae asphodeloides Bunge (Liliaceae), was investigated in Saccharomyces cerevisiae. Five bioconversion products, denoted compounds 2-6, were obtained. Biotransformation metabolite 2 was a stereoisomer of TAIII with a specific isotype F-ring and beta-ranged CH3-21, which rarely occurs in nature. The structure of 2 was elucidated by extensive spectroscopic analysis (H-H COSY, HSQC, HMBC), as well as by high-resolution mass spectral analysis. The growth inhibitory activity of compounds 1-6 was assayed against four human cancer cell lines, HepG2, H-1299, HT-29, and HCT-116. Compounds 1 and 2 obviously inhibited the growth of the four types of cancer cells with IC50 values being less than 19 micrometer. A structure-activity relationship is discussed, and the spirostane-ring F in compounds 1 and 2 appears to be the critical bioactive moiety for the cell growth inhibitory property.

摘要

从百合科知母根茎中分离得到的主要甾体皂甙之一知母皂甙 A-III(TA-III)在酿酒酵母中进行了生物转化研究。得到了五个生物转化产物,分别表示为化合物 2-6。生物转化代谢产物 2 是 TAIII 的立体异构体,具有特定的 F 环和β范围的 CH3-21,这在自然界中很少见。通过广泛的光谱分析(H-H COSY、HSQC、HMBC)以及高分辨率质谱分析,确定了 2 的结构。对化合物 1-6 对四种人类癌细胞系 HepG2、H-1299、HT-29 和 HCT-116 的生长抑制活性进行了测定。化合物 1 和 2 明显抑制了四种类型的癌细胞的生长,IC50 值小于 19 微米。讨论了构效关系,化合物 1 和 2 中的螺甾烷环 F 似乎是细胞生长抑制特性的关键生物活性部分。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验